Duopharma Biotech Berhad Accounts Payable for the year ending December 31, 2024: USD 14.67 M

Duopharma Biotech Berhad Accounts Payable is USD 14.67 M for the year ending December 31, 2024, a 66.79% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
  • Duopharma Biotech Berhad Accounts Payable for the year ending December 31, 2023 was USD 8.80 M, a 348.82% change year over year.
  • Duopharma Biotech Berhad Accounts Payable for the year ending December 31, 2022 was USD 1.96 M, a -73.88% change year over year.
  • Duopharma Biotech Berhad Accounts Payable for the year ending December 31, 2021 was USD 7.50 M, a 7.42% change year over year.
  • Duopharma Biotech Berhad Accounts Payable for the year ending December 31, 2020 was USD 6.99 M, a -17.41% change year over year.
Key Data
Date Accounts Payable Short-Term Debt Long-Term Debt Total Liabilities